Pfiz­er’s make-or-break quar­ter

Tues­day could be the most im­por­tant quar­ter­ly re­port of Pfiz­er CEO Al­bert Bourla’s ca­reer.

When the drug­mak­er re­leas­es third-quar­ter re­sults around 7 a.m., the world …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA